1 – 10 of 322
- show: 10
- |
- sort: year (new to old)
- |
- Export
- 2024
-
Distinct Infiltration of T Cell Populations in Bladder Cancer Molecular Subtypes
(2024)
In Cells
13(11).
- Contribution to journal › Article
- 2023
-
An artificial intelligence-powered, patient-centric digital tool for self-management of chronic pain : a prospective, multicenter clinical trial
(2023)
In Pain Medicine (United States)
24(9).
p.1100-1110
- Contribution to journal › Article
-
Protein Biomarker Signatures in Precision Diagnostics of Cancer
(2023)
p.487-505
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2022
-
One-year recovery from breast cancer : Importance of tumor and treatment-related factors, resilience, and sociodemographic factors for health-related quality of life
(2022)
In Frontiers in Oncology
12.
- Contribution to journal › Article
-
Transcriptional profiling demonstrates altered characteristics of CD8 + cytotoxic T-cells and regulatory T-cells in TP53-mutated acute myeloid leukemia
(2022)
In Cancer Medicine
11(15).
p.3023-3032
- Contribution to journal › Article
- 2021
-
Fluorescence signal enhancement in antibody microarrays using lightguiding nanowires
(2021)
In Nanomaterials
11(1).
- Contribution to journal › Article
-
Comprehending the proteomic landscape of ovarian cancer : A road to the discovery of disease biomarkers
(2021)
In Proteomes
9(2).
- Contribution to journal › Scientific review
-
The Value of a New Diagnostic Test for Prostate Cancer : A Cost-Utility Analysis in Early Stage of Development
(2021)
In PharmacoEconomics - Open
5(1).
p.77-88
- Contribution to journal › Article
-
Identification of a serum biomarker signature associated with metastatic prostate cancer
(2021)
In Proteomics - Clinical Applications
15(2-3).
- Contribution to journal › Article
- 2020
-
Animal-derived-antibody generation faces strict reform in accordance with European Union policy on animal use
(2020)
In Nature Methods
17(8).
p.755-756
- Contribution to journal › Letter